Danaher Corporation $DHR Stock Sold by Middleton & Co. Inc. MA

Middleton & Co. Inc. MA cut its holdings in shares of Danaher Corporation (NYSE:DHR) by 3.7% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 64,130 shares of the conglomerate’s stock after selling 2,436 shares during the period. Danaher accounts for approximately 1.5% of Middleton & Co. Inc. MA’s holdings, making the stock its 21st biggest holding. Middleton & Co. Inc. MA’s holdings in Danaher were worth $14,208,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in DHR. Main Street Group LTD acquired a new position in Danaher in the first quarter valued at approximately $25,000. N.E.W. Advisory Services LLC bought a new position in Danaher in the second quarter valued at approximately $25,000. Marquette Asset Management LLC grew its holdings in Danaher by 192.1% during the 3rd quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock worth $25,000 after acquiring an additional 73 shares during the period. Evolution Wealth Management Inc. grew its holdings in Danaher by 208.0% during the 1st quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate’s stock worth $29,000 after acquiring an additional 104 shares during the period. Finally, Field & Main Bank acquired a new stake in Danaher during the 2nd quarter worth $29,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting Danaher

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Danaher reported third-quarter adjusted earnings of $2.11 per share, above the $1.92 analyst consensus, while revenue reached approximately $6.55 billion. Revenue increased 8.3% year over year, and management raised its full-year 2026 adjusted EPS outlook. Danaher 3Q Net Up Sharply as Company Boosts 2026 Adjusted EPS View
• Positive Sentiment: Analysts raised their valuation targets following the results. TD Cowen and JPMorgan lifted targets to $270, Goldman Sachs raised its target to $275, Stifel increased its target to $260, and Robert W. Baird raised its target to $254. The firms maintained bullish ratings, including Buy, Overweight and Outperform. Danaher Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Earnings
• Positive Sentiment: Management highlighted margin strength, improved execution and an increased focus on innovation and artificial intelligence, factors analysts viewed as supporting a better longer-term outlook. Danaher Earnings Call Highlights Margin Strength, AI Push
• Neutral Sentiment: Despite the earnings beat and higher targets, shares declined in the immediate post-results reaction, suggesting investors may have already priced in much of the improvement. A recent valuation comparison also frames DHR as a stock for investors weighing quality and growth against its relatively elevated valuation. Danaher Q3 Recap: Decent Results, Still A Hold
• Negative Sentiment: Danaher’s new CEO emphasized the need for better execution and innovation. TD Cowen cited tariff pressure and a cautious 2027 outlook, creating uncertainty beyond the raised 2026 guidance and helping explain why the stock did not fully respond to the strong quarterly report. Danaher Posts First Earnings Under New CEO

Danaher Stock Up 0.3%

Danaher stock opened at $230.36 on Friday. The company’s 50 day simple moving average is $216.32 and its 200 day simple moving average is $197.35. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The firm has a market capitalization of $162.07 billion, a price-to-earnings ratio of 37.70, a PEG ratio of 2.88 and a beta of 0.76. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.63 and a quick ratio of 1.25.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.92 by $0.19. The firm had revenue of $6.55 billion during the quarter, compared to analysts’ expectations of $6.56 billion. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The business’s revenue for the quarter was up 8.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.89 earnings per share. As a group, sell-side analysts anticipate that Danaher Corporation will post 8.59 EPS for the current year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be given a $0.40 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. Danaher’s dividend payout ratio is currently 26.19%.

Wall Street Analysts Forecast Growth

Several analysts have commented on DHR shares. Morgan Stanley upped their target price on shares of Danaher from $220.00 to $240.00 and gave the company an “overweight” rating in a research report on Monday, October 12th. Stifel Nicolaus raised their price target on Danaher from $220.00 to $260.00 and gave the stock a “buy” rating in a research report on Thursday. JPMorgan Chase & Co. lifted their price objective on Danaher from $250.00 to $270.00 and gave the stock an “overweight” rating in a research note on Thursday. Guggenheim lifted their price objective on Danaher from $200.00 to $250.00 and gave the stock a “buy” rating in a research note on Thursday, October 1st. Finally, Wall Street Zen downgraded Danaher from a “buy” rating to a “hold” rating in a report on Sunday, October 18th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $242.91.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.